Clinical trial
The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota
NCT03462875 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 29, 2018
- Completion date
- February 28, 2024
- Enrollment
- 532 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.